» Articles » PMID: 31508565

Expression of MiR-302 in Human Embryo Derived from In-vitro Matured Oocyte

Overview
Date 2019 Sep 12
PMID 31508565
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The expression of miR-302 over the period of early embryogenesis could possibly regulate the maternal transcript clearance. Zygotic transcription activation is mostly related to maternal messages degradation.

Objective: In this study, the effects of in-vitro maturation technique (IVM) on the expression of miR-302 in human embryo produced from immature and mature human oocytes (matured in vitro and in vivo, before sperm exposure) obtained from females under gonadotrophin therapy were evaluated for assisted reproduction.

Materials And Methods: Immature oocytes were cultured in vitro. The injection of oocytes-producing polar bodies was given using fresh sperm. Then, the embryo quality score was assessed in the IVM group compared with the control group. In both the groups, embryos with normal morphology were included in the molecular study. Only one blastomere was removed from three-day embryos and then the embryos were frozen. The expression of miR-302 in embryos was measured through quantitative real-time polymerase chain reaction.

Results: Our data showed a significant reduction of miR-302 expression in the IVM group vs. the control group (p = 0.02). The embryo quality score showed a significant difference between the two groups (p = 0.01).

Conclusion: The present study demonstrated that the IVM process had a negative effect on the expression level of miR-302 in human pre-implantation embryos. Considering the major role of expression miR-302, a reduced potential in miR-302 expression could be related to a decrease in the early embryonic development.

Citing Articles

Transcriptome Analysis Reveals miR-302a-3p Affects Granulosa Cell Proliferation by Targeting in Chickens.

Liu Y, Zhou Z, Zhang H, Han H, Yang J, Li W Front Genet. 2022; 13:832762.

PMID: 35432481 PMC: 9006144. DOI: 10.3389/fgene.2022.832762.


Oocyte activation deficiency and assisted oocyte activation: mechanisms, obstacles and prospects for clinical application.

Kashir J, Ganesh D, Jones C, Coward K Hum Reprod Open. 2022; 2022(2):hoac003.

PMID: 35261925 PMC: 8894871. DOI: 10.1093/hropen/hoac003.


Detection of Novel Potential Regulators of Stem Cell Differentiation and Cardiogenesis through Combined Genome-Wide Profiling of Protein-Coding Transcripts and microRNAs.

Machado R, Sachinidis A, Futschik M Cells. 2021; 10(9).

PMID: 34572125 PMC: 8469649. DOI: 10.3390/cells10092477.


Association of miR-146a and miR196a2 genotype with susceptibility to idiopathic recurrent pregnancy loss in Iranian women: A case-control study.

Babakhanzadeh E, Danaei H, Abedinzadeh M, Ashrafzadeh H, Ghasemi N Int J Reprod Biomed. 2021; 19(8):725-732.

PMID: 34568733 PMC: 8458919. DOI: 10.18502/ijrm.v19i8.9620.

References
1.
Sousa P, Caveney A, Westhusin M, Watson A . Temporal patterns of embryonic gene expression and their dependence on oogenetic factors. Theriogenology. 2000; 49(1):115-28. DOI: 10.1016/s0093-691x(97)00406-8. View

2.
De La Fuente R, Eppig J . Transcriptional activity of the mouse oocyte genome: companion granulosa cells modulate transcription and chromatin remodeling. Dev Biol. 2001; 229(1):224-36. DOI: 10.1006/dbio.2000.9947. View

3.
Zuccotti M, Boiani M, Ponce R, Guizzardi S, Scandroglio R, Garagna S . Mouse Xist expression begins at zygotic genome activation and is timed by a zygotic clock. Mol Reprod Dev. 2002; 61(1):14-20. DOI: 10.1002/mrd.1126. View

4.
Katayama K, Stehlik J, Kuwayama M, Kato O, Stehlik E . High survival rate of vitrified human oocytes results in clinical pregnancy. Fertil Steril. 2003; 80(1):223-4. DOI: 10.1016/s0015-0282(03)00551-x. View

5.
Houbaviy H, Murray M, Sharp P . Embryonic stem cell-specific MicroRNAs. Dev Cell. 2003; 5(2):351-8. DOI: 10.1016/s1534-5807(03)00227-2. View